Lavipharm S.A.
LAVI | AT
Overview
Corporate Details
- ISIN(s):
- GRS246003008
- LEI:
- 213800USC69CRPRGWJ15
- Country:
- Greece
- Address:
- AGIAS MARINAS STR, 19002 PAIANIA
- Website:
- https://lavipharm.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Established in 1911, Lavipharm is today an integrated group of companies engaged in the research, development, manufacturing, import, marketing and sales, wholesaling and 3PL of pharmaceutical, dermocosmetic and healthcare products in Greece, with a strong international activity. Our key features: ▪ Strong global player in pharmaceutical technologies with expertise on transdermal drug delivery systems ▪ Focus on international expansion ▪ Partner of choice for major international pharmaceutical and consumer health companies in Greece and abroad ▪ An innovator in specialty pharmacy services establishing a dynamic network across Greece ▪ Well-positioned for short, medium and long term growth
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-11 16:30 |
General Meeting Notice
ΠΡΟΣΚΛΗΣΗ ΣΕ ΤΑΚΤΙΚΗ ΓΕΝΙΚΗ ΣΥΝΕΛΕΥΣΗ
|
Greek (modern) | 191.0 KB | |
| 2025-05-15 16:19 |
Regulatory News Service
Βασικά Οικονομικά Μεγέθη A Τριμήνου 2025
|
Greek (modern) | 118.2 KB | |
| 2025-05-15 16:19 |
Regulatory News Service
Financial Results Q1 2025
|
English | 92.6 KB | |
| 2025-04-24 16:39 |
Regulatory News Service
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΕΝΗΜΕΡΩΣΗ ΕΙΣΗΓΜΕΝΗΣ ΠΡΟΣ ΑΝΑΛΥΤΕΣ
|
Greek (modern) | 1.0 MB | |
| 2025-04-24 16:39 |
Regulatory News Service
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΕΝΗΜΕΡΩΣΗ ΕΙΣΗΓΜΕΝΗΣ ΠΡΟΣ ΑΝΑΛΥΤΕΣ
|
Greek (modern) | 116.5 KB | |
| 2025-04-24 16:39 |
Regulatory News Service
Annual Analists Briefing
|
English | 61.4 KB | |
| 2025-04-24 16:39 |
Regulatory News Service
Annual Analists Briefing
|
English | 1.0 MB | |
| 2025-04-14 16:55 |
Regulatory News Service
ΔΕΛΤΙΟ ΤΥΠΟΥ
|
Greek (modern) | 206.9 KB | |
| 2025-04-03 20:34 |
Annual Report (ESEF)
Οικονομική Έκθεση LAVIPHARM Α.Ε. (2024,Ετήσιος Ισολογισμός,Μητρική-Ενοποιημένη)…
|
Greek (modern) | 2.9 MB | |
| 2025-04-03 20:34 |
Annual Report (ESEF)
Financial Report LAVIPHARM S.A. (2024,Year Statement,Both)-iXBRL
|
English | 2.1 MB | |
| 2024-03-21 18:55 |
Annual Report (ESEF)
Οικονομική Έκθεση LAVIPHARM Α.Ε. (2023,Ετήσιος Ισολογισμός,Μητρική-Ενοποιημένη)…
|
Greek (modern) | 3.6 MB | |
| 2023-03-27 19:46 |
Annual Report (ESEF)
Οικονομική Έκθεση LAVIPHARM Α.Ε. (2022,Ετήσιος Ισολογισμός,Μητρική-Ενοποιημένη)…
|
Greek (modern) | 1.8 MB | |
| 2022-03-21 18:15 |
Annual Report (ESEF)
Οικονομική Έκθεση LAVIPHARM Α.Ε. (2021,Ετήσιος Ισολογισμός,Μητρική-Ενοποιημένη)…
|
Greek (modern) | 4.4 MB | |
| 2015-10-01 00:00 |
Annual Report
Financial Statement and Information LAVIPHARM S.A. (2007,Year Statement,Both)
|
English | 118.5 KB | |
| 2015-09-28 00:00 |
Interim Report
Financial Statement - Full Notes LAVIPHARM S.A. (2007,Six-Month Statement,Compa…
|
English | 143.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
MorphoSys AG | Germany | MOR | |
|
MPH Health Care | Germany | 93M1 | |
|
NATAC | Spain | NAT | |
|
Navamedic | Norway | NAVA | |
|
Newbury Pharmaceuticals AB | Sweden | NEWBRY | |
|
New Nordic Healthbrands AB | Sweden | NNH | |
|
Nicoccino Holding AB | Sweden | NICO | |
|
Nicox S.A. | France | COX | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI |